Logo Logo
Hilfe
Hilfe
Switch Language to English

Hoffmann, Gordon Victor ORCID logoORCID: https://orcid.org/0009-0007-3167-2124; Gottschlich, Adrian ORCID logoORCID: https://orcid.org/0000-0002-2898-4182; Subklewe, Marion ORCID logoORCID: https://orcid.org/0000-0001-9154-9469 und Kobold, Sebastian ORCID logoORCID: https://orcid.org/0000-0002-5612-4673 (Juni 2025): Novel approaches to CAR T cell target identification in acute myeloid leukemia. In: Current Opinion in Pharmacology, Bd. 82, 102524 [PDF, 725kB]

Abstract

Identifying safe and effective CAR T cell targets in acute myeloid leukemia (AML) is challenging due to the disease’s complexity and overlap with normal hematopoiesis. This review highlights advances in target discovery for AML, emphasizing innovative approaches. Structural surfaceomics identifies tumor-specific protein conformations, while AI-driven single-cell RNA sequencing integrates multi-source data to pinpoint optimal targets. Refined cell surface capture technology maps the AML surfaceome without relying on predefined antibodies. These strategies enhance CAR T cell specificity and minimize off-tumor effects, offering promising pathways for safer and more effective AML treatments and broader cancer therapies.

Dokument bearbeiten Dokument bearbeiten